VDAC1 and Vascular dilatation: In the present study, by utilizing commercially available healthy and diseased human samples as well as rat myocardial samples, we demonstrate an increase in the expressed levels of VDAC1 in the setting of common cardiac pathologies including in the post-MI setup, chronic LV dilatation and dysfunction, and hyperaldosteronism.